This episode of T.O.P. is brought to you by Ronin Surgical, the market leader in surgical illumination. When you're focused on delivering the best outcomes for your patients, your equipment should work seamlessly alongside you. That's why Ronin Surgical developed the X7 Surgical Headlight System—engineered to be lighter, brighter, and longer-lasting than any other operating room headlight. With innovative features like High Intensity Mode and hot-swap capabilities, the X7 delivers superior illumination when it matters most. Learn more at www.roninsurgical.com/

Moderator: Natalie Hoesly, MD FACS

Participants: - Bobby Korn, MD PhD FACS - Michael McCracken, MD FACS - Ivan Vrcek, MD FACS - Robert Schwarcz, MD FACS

Podcast Description: Now on TOP: Join us for another Surgical Technique Battle, focusing on anterior lamella management strategies in lower blepharoplasty surgery

Dr. Natalie Hoesly hosts Dr. Bobby Korn, Dr. Micahel McCracken, Dr. Robert Schwarcz and Dr. Ivan Vrcek to a discussion of anterior lamella management strategies in lower blepharoplasty surgery, including chemical peel, laser resurfacing, skin pinch and skin/muscle suspension techniques.

Host: Dr. Jonathan Lu Panelists: Dr. Michael Burnstine, Dr. Alon Kahana, and Dr. Nickisa Hodgson

In this episode of The Oculofacial Podcast Journal Club, three interesting studies from the May/June 2026 issue of the OPRS Journal are summarized and discussed by experts in the field. Topics will include projected workforce needs in oculofacial plastic surgery, intravitreal injection related eyelid ptosis, and GLP-1 medications' impact on the face. The panelists will guide listeners through these studies while also adding their own perspectives and experiences.

We are joined by Dr. Peter Timoney, director of the spring meeting to recap all the highlights and get some behind the scenes insight. Dr. Lilly Wagner recaps the Orbit and Oncology sessions with her favorite take-aways and Dr. Katie Winkler shares the best of the Aesthetics and Practice Management sessions.

In this episode, ASOPRS Immediate Past President, Dr. Wendy Lee, moderates a candid roundtable with Drs. Don Kikkawa, John Holds, Evan Black, and Reza Vagefi, as they discuss ACGME accreditation of fellowship training.

The panel weighs external validation, standardized training, and the potential for a new ABO subspecialty certification in the setting of ACGME requirements and some program director concerns about those requirements. Both ACGME accreditation of fellowships and participation in ABO Continuing Certification are two key components of an ABMS-compliant certification.

Whether you're a member or simply invested in the future of oculofacial plastic surgery, this conversation is essential listening.

Moderator: Dr. Deepak Ramesh

Guests: Dr. Rod Rohrich and Dr. John Holds

In the dynamic world of oculofacial plastic surgery, trends come and go, but some principles remain timeless. This post explores the evolution of eyelid surgery, the shift towards natural aesthetics, and the future of oculoplastics based on insights from leading experts in the field.

Moderator:

Cat Burkat, MD FACS (Professor at Univ of Wisconsin-Madison)

Guests

· Dr. Elizabeth Bradley, Associate Professor at the Mayo Clinic, Rochester

· Dr. François Codère Associate Professor from the Université de Montréal in Canada

· Dr. Richard Allen, Professor at Baylor in Texas

In this Surgical Spotlight TOP podcast episode: "Myogenic Ptosis: Is It Really Any Different?", we are diving into a topic that most oculoplastic surgeons encounter—but rarely explore in depth: the surgical management of myogenic ptosis in progressive conditions such as Oculopharyngeal Muscular Dystrophy and Chronic Progressive External Ophthalmoplegia. We'll explore how the natural history of myogenic ptosis may change surgical decision-making. Should timing and the selected procedure be driven not just by the exam—but by disease trajectory? Does earlier onset signal a more aggressive course, pushing us toward more proactive surgery rather than a traditional stepwise approach? And how should we rethink concepts like recurrence, failure, and even surgical success when progression is expected?

Tune in as we discuss the challenge of correcting myogenic ptosis—for today, and where the patient will be years from now.

In this episode of The Oculofacial Podcast, host Dr. David Samimi is joined by an expert panel including Drs. Larry Kass, Allen Wulc, Julian Perry, and Adam Scheiner to discuss the management of one of the more challenging problems in aesthetic and reconstructive oculoplastic surgery – lower eyelid festoons and malar mounds. The conversation covers topics including patient evaluation, treatment selection, laser resurfacing, injectable tetracycline, surgical techniques, midface lifting, fat grafting, direct festoon excision, and pearls for avoiding complications and recurrence. They also discuss why patient counseling and expectation management are critical to achieving successful outcomes. Each expert offers their own personal experience in the treatment of festoons to deliver expert insights and treatment and surgical pearls.

Disclaimer: The opinions and perspectives expressed by participants are their own and are shared for informational discussion purposes only. Statements made during the podcast may not be those of ASOPRS or the ASOPRS Board of Directors.

About This Episode

ASOPRS President Dr. John Ng moderates a panel discussion on subspecialty board certification, why it matters now, and what it would mean for members.

Panelists

• Dr. Ken Morgenstern — Board Certification Liaison, Former ASOPRS President
• Dr. Stuart Seiff — Executive Vice President, Former ASOPRS President
• Dr. Jennifer Murdock — ASOPRS Member
• Dr. George Bartley — CEO, American Board of Ophthalmology
• Dr. Jill Foster — Former ASOPRS President

Key Topics Covered

• Why credentialing, legal, and advocacy pressures have made board certification a priority for ASOPRS to support
• The case for ABO subspecialty certification
• One member's firsthand experience regarding denial of ASC privileges
• The ABO's commitment to making ophthalmic plastic & reconstructive surgery the first ophthalmology subspecialty
• ACGME fellowship requirements: Key differences, challenges, and potential solutions

Disclaimer: The opinions and perspectives expressed by participants are their own and are shared for informational discussion purposes only. Statements made during the podcast may not be those of ASOPRS or the ASOPRS Board of Directors.

ASOPRS Website: Click Here

Host: Deepak Ramesh

In this episode of the ASOPRS Oculofacial Podcast, host Dr. Deepak Ramesh is joined by Drs. Gary Linkov and Mike McCracken to explore the evolving role of hair transplantation within oculoplastic surgery. From foundational principles like androgenetic hair loss and donor site selection to advanced techniques such as FUE vs. FUT, eyebrow restoration, and patient selection, the discussion blends science, artistry, and real-world practice insights. Whether you're considering incorporating hair restoration into your practice or simply want to better understand its nuances, this episode delivers practical pearls, business considerations, and future-forward perspectives on this growing subspecialty

ASOPRS Website: Click Here

Host: Dr. Jamie Keen

Panelists: Dr. Stuart R. Seiff, Dr. Erin Shriver, and Dr. Kathryn (Katie) Winkler

Producer: Seanna Grob

In this episode of The Oculofacial Podcast Journal Club, host Dr. Jamie Keen is joined by an esteemed panel of leaders in oculoplastic surgery; Dr. Stuart Seiff, Dr. Erin Shriver, and Dr. Katie Winkler to review and discuss three impactful studies from the March/April 2026 issue of the OPRS Journal. The conversation explores long-term brow lift outcomes through a systematic review and meta-analysis, evaluates key predictors of facial asymmetry in unilateral anophthalmia and microphthalmia, and examines the relationship between socioeconomic factors and periocular basal cell carcinoma treated with Mohs surgery. Each expert brings thoughtful insight into the strengths, limitations, and real-world implications of these studies, offering valuable perspective on how emerging research may influence clinical decision-making and patient care in oculofacial plastic surgery.